title: ASPECCT: panitumumab versus cetuximab for colorectal cancer.
authors.affiliation: Department of Medical Oncology, Eastern Health, Box Hill, VIC, Australia; Department of Oncology, Level 4, Olivia Newton-John Cancer and Wellness Centre, Austin Hospital, PO Box 5555, Heidelberg, VIC 3084, Australia. Electronic address: eliza.hawkes@monash.edu.
authors.forename: Eliza A
authors.initials: EA
authors.lastname: Hawkes
authors.affiliation: Department of Medical Oncology, Eastern Health, Box Hill, VIC, Australia.
authors.forename: Rachel
authors.initials: R
authors.lastname: Wong
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D015179:Colorectal Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents